Logo image of RGI.CA

RECO INTERNATIONAL GROUP INC (RGI.CA) Stock Fundamental Analysis

Canada - TSX-V:RGI - CA75622R1001 - Common Stock

0.015 CAD
0 (0%)
Last: 10/16/2025, 7:00:00 PM
Fundamental Rating

1

Taking everything into account, RGI scores 1 out of 10 in our fundamental rating. RGI was compared to 7 industry peers in the Construction & Engineering industry. RGI may be in some trouble as it scores bad on both profitability and health. RGI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RGI had negative earnings in the past year.
RGI had a positive operating cash flow in the past year.
RGI.CA Yearly Net Income VS EBIT VS OCF VS FCFRGI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 200K -200K -400K -600K -800K

1.2 Ratios

The Return On Assets of RGI (-94.12%) is worse than 85.71% of its industry peers.
Industry RankSector Rank
ROA -94.12%
ROE N/A
ROIC N/A
ROA(3y)-44.36%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RGI.CA Yearly ROA, ROE, ROICRGI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 100 -100 200 300

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for RGI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RGI.CA Yearly Profit, Operating, Gross MarginsRGI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 -10 -20 -30

More info and screens

3

2. Health

2.1 Basic Checks

RGI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RGI remains at a similar level compared to 1 year ago.
Compared to 1 year ago, RGI has an improved debt to assets ratio.
RGI.CA Yearly Shares OutstandingRGI.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M 40M
RGI.CA Yearly Total Debt VS Total AssetsRGI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500K 1M 1.5M 2M

2.2 Solvency

Based on the Altman-Z score of -8.33, we must say that RGI is in the distress zone and has some risk of bankruptcy.
RGI has a Altman-Z score of -8.33. This is amonst the worse of the industry: RGI underperforms 85.71% of its industry peers.
RGI has a debt to FCF ratio of 3.14. This is a good value and a sign of high solvency as RGI would need 3.14 years to pay back of all of its debts.
RGI's Debt to FCF ratio of 3.14 is amongst the best of the industry. RGI outperforms 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.14
Altman-Z -8.33
ROIC/WACCN/A
WACC9.31%
RGI.CA Yearly LT Debt VS Equity VS FCFRGI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 500K -500K -1M

2.3 Liquidity

A Current Ratio of 0.19 indicates that RGI may have some problems paying its short term obligations.
RGI has a Current ratio of 0.19. This is amonst the worse of the industry: RGI underperforms 85.71% of its industry peers.
A Quick Ratio of 0.19 indicates that RGI may have some problems paying its short term obligations.
RGI has a Quick ratio of 0.19. This is amonst the worse of the industry: RGI underperforms 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.19
RGI.CA Yearly Current Assets VS Current LiabilitesRGI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for RGI have decreased strongly by -80.58% in the last year.
RGI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.01%.
EPS 1Y (TTM)-80.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-375%
Revenue 1Y (TTM)9.01%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-38.99%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RGI.CA Yearly Revenue VS EstimatesRGI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 1M 2M 3M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RGI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RGI.CA Price Earnings VS Forward Price EarningsRGI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, RGI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.72
EV/EBITDA N/A
RGI.CA Per share dataRGI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RGI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RECO INTERNATIONAL GROUP INC

TSX-V:RGI (10/16/2025, 7:00:00 PM)

0.015

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners32.81%
Ins Owner ChangeN/A
Market Cap744.60K
Revenue(TTM)3.80M
Net Income(TTM)-922500
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF 6.72
P/OCF 6.45
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY14.88%
OCF(TTM)0
OCFY15.51%
SpS0.08
BVpS-0.04
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -94.12%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 2.92%
ROA(3y)-44.36%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover3.87
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.14
Debt/EBITDA N/A
Cap/Depr 1.76%
Cap/Sales 0.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.19
Altman-Z -8.33
F-Score3
WACC9.31%
ROIC/WACCN/A
Cap/Depr(3y)0.87%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.07%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-80.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-375%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.01%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-38.99%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-85.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y519.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y547.91%
OCF growth 3YN/A
OCF growth 5YN/A